1. Rapid Antiretroviral Therapy Program: Development and Evaluation at a Veterans Affairs Medical Center in the Southern United States
- Author
-
Jesse G. O'Shea, Julia W. Gallini, Xiangqin Cui, Abeer Moanna, and Vincent C. Marconi
- Subjects
Male ,Anti-HIV Agents ,Clinical and Epidemiologic Research ,Public Health, Environmental and Occupational Health ,HIV Infections ,Integrase Inhibitors ,Viral Load ,United States ,CD4 Lymphocyte Count ,Infectious Diseases ,Humans ,Female ,Retrospective Studies ,Veterans - Abstract
Early HIV viral suppression (VS) improves individual health outcomes and decreases onward transmission. We designed an outpatient clinic protocol to rapidly initiate antiretroviral therapy (ART) in a large Veterans Health Administration (VA) HIV clinic. A pre–post evaluation was performed using a retrospective cohort study design for new diagnoses of HIV infection from January 2012 to February 2020. Time-to-event analyses were performed using the Cox proportional hazards model with the intervention group as the main exposure adjusted for integrase inhibitor usage, baseline viral load, age, gender, and race. Most of the patients were men (historical control: 94.8%, n = 55; Rapid Start: 94.8%, n = 55) and Black or African American persons (historical control: 87.9%, n = 51; Rapid Start: 82.8%, n = 48). More patients initiated treatment with an integrase inhibitor-based regimen in the Rapid Start group (98.3%, n = 57) compared with the historical control group (39.7%, n = 23). Compared with controls, the Rapid Start patients were significantly more likely to achieve VS at any given time during the study period (hazard ratio 2.65; p
- Published
- 2022
- Full Text
- View/download PDF